Correlations between Fibromyalgia Symptom and Function Domains and Patient Global Impression of Change: A Pooled Analysis of Three Randomized, Placebo-Controlled Trials of Pregabalin

Pain Medicine

Volumn 12, Issue 2, 2011, Pages 260-267

  Arnold, Lesley M ^a   Zlateva, Gergana ^b   Sadosky, Alesia ^b   Emir, Birol ^b   Whalen, Ed ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Pfizer Global Pharmaceuticals   (United States)

Author keywords

Fatigue; Fibromyalgia; Pain; Pregabalin; Sleep

Indexed keywords

PLACEBO; PREGABALIN;

ADULT; ANALYSIS; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CORRELATION COEFFICIENT; DATA ANALYSIS; DEPRESSION; FATIGUE; FEMALE; FIBROMYALGIA; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREDICTOR VARIABLE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 36; SLEEP; SOCIAL STATUS; SYMPTOM; WORK;

EID: 79751532539     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.01047.x     Document Type: Article

References (22)

1. Wolfe F, Smythe HA, Yunus MB, etal. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
3. Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: A comparative analysis. J Rheumatol 1993;20:475-9.
4. Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6-21.
5. Mease P, Arnold LM, Choy EH, etal. Fibromyalgia syndrome module at OMERACT 9: Domain construct. J Rheumatol 2009;36:2318-29.
6. Mease PJ, Russell IJ, Arnold LM, etal. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35:502-14.
7. Arnold LM, Russell IJ, Diri EW, etal. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008;9:792-805.
8. Pauer L, Danneskiold-Samsoe B, Jespersen A, etal. Pregabalin for management of fibromyalgia (FM): A 14-week, randomized, double-blind, placebo-controlled, monotherapy trial [abstract no. 382]. Ann Rheum Dis 2008;67(suppl II):256.
9. Dworkin RH, Turk DC, Farrar JT, etal. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19.
10. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991;18:728-33.
11. Hays RD, Stewart AL. Sleep measures. In: Stewart AL, Ware JE Jr, eds. Measuring Functioning and Well-Being. Durham, NC: Duke University Press; 1992:235-9.
12. Belza B, Henke C, Yelin E, Epstein WV, Gillis CL. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993;42:93-9.
13. Zigmond A, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
14. ® Health Survey. Lincoln, RI: Quality Metric Incorporated; 2000.
15. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc; 1977.
16. Hoeffding W. A non-parametric test of independence. Ann Math Stat 1948;19:546-57.
17. Fujita A, Sato JR, Demasi MA, etal. Comparing Pearson, Spearman and Hoeffding's D measure for gene expression association analysis. J Bioinform Comput Biol 2009;7(4):663-84.
18. Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B 1996;52:267-88.
19. Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B 2005;67:301-20.
20. Hudson JI, Arnold LM, Bradley LA, etal. What makes fibromyalgia patients feel better? Correlations between patient global impression of improvement and changes in clinical symptoms and function: A pooled analysis of four, randomized, placebo-controlled trials of duloxetine. J Rheumatol 2009;36:2517-22.
21. Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R. Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain 2010;149:373-8.
22. Choy EH, Arnold LM, Clauw DJ, etal. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 2009;36:2330-4.